News
Par Drugs & Chemicals standalone net profit declines 48.48% in the March 2026 quarter
15-May-2026 | 07:36
Sales decline 12.18% to Rs 19.61 crore
Net profit of Par Drugs & Chemicals declined 48.48% to Rs 0.85 crore in the quarter ended March 2026 as against Rs 1.65 crore during the previous quarter ended March 2025. Sales declined 12.18% to Rs 19.61 crore in the quarter ended March 2026 as against Rs 22.33 crore during the previous quarter ended March 2025.
For the full year,net profit declined 1.87% to Rs 13.11 crore in the year ended March 2026 as against Rs 13.36 crore during the previous year ended March 2025. Sales rose 2.66% to Rs 103.66 crore in the year ended March 2026 as against Rs 100.97 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 19.61 | 22.33 | -12 | 103.66 | 100.97 | 3 |
| OPM % | 7.29 | 10.88 | - | 16.53 | 19.32 | - |
| PBDT | 1.75 | 3.20 | -45 | 21.00 | 21.58 | -3 |
| PBT | 0.82 | 2.28 | -64 | 17.30 | 17.93 | -4 |
| NP | 0.85 | 1.65 | -48 | 13.11 | 13.36 | -2 |
Powered by Capital Market - Live News
